Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis

Sara Jaafar, Scott Visovatti, Amber Young, Suiyuan Huang, Paul Cronin, Dharshan Vummidi, Vallerie McLaughlin, Dinesh Khanna

Source: Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019
Journal Issue: August
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sara Jaafar, Scott Visovatti, Amber Young, Suiyuan Huang, Paul Cronin, Dharshan Vummidi, Vallerie McLaughlin, Dinesh Khanna. Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis. Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018



Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019


Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis
Source: Eur Respir J 2016; 48: 1658-1667
Year: 2016



Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004

Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018



Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018



Clinical and autoantibody features of right-heart catheter-proven pulmonary hypertension in systemic sclerosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

Predictors of pulmonary artery hypertension in patients with systemic sclerosis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012


Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018



Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management
Source: Eur Respir Rev 2010 19: 314-320
Year: 2010



Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014


Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Ergospirometry findings in patients with scleroderma in relation to concurrent pulmonary hypertension
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010

Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009



Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008